Insider · CIK 0001713070
Shehnaaz Suliman
Files at: TXG, TBPH, RARE. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 4:30 pm EDT | 10x Genomics, Inc.TXG | 5,723 | $81.19 | $464,668 | 23,792 | −19.4% | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 4:42 pm EDT | 10x Genomics, Inc.TXG | 2,207 | $63.65 | $140,478 | 29,515 | −6.96% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 18, 4:08 pm EDT | 10x Genomics, Inc.TXG | 5,723 | $32.63 | $186,756 | 31,722 | −15.3% | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:26 pm EDT | 10x Genomics, Inc.TXG | 8,829 | — | — | 37,445 | — | |
| Feb 20, 2019 FForm 4 → | Feb 22, 6:23 pm EST | Theravance Biopharma, Inc.TBPH | 5,763 | $27.00 | $155,601 | 97,198 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 5:41 pm EST | Theravance Biopharma, Inc.TBPH | 8,770 | $29.09 | $255,119 | 101,230 | — | plan? |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:23 pm EST | Theravance Biopharma, Inc.TBPH | 90,000 | — | — | 110,000 | — | plan? |
| Aug 1, 2017 AForm 4 → | Aug 3, 6:12 pm EDT | Theravance Biopharma, Inc.TBPH | 20,000 | — | — | 20,000 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2019 AForm 4 → | Feb 1, 7:25 pm EST | Ultragenyx Pharmaceutical Inc.RARE | 20,000 | — | — | 20,000 | — | |
| Aug 1, 2017 AForm 4 → | Aug 3, 6:12 pm EDT | Theravance Biopharma, Inc.TBPH | 170,000 | — | — | 170,000 | — |